Charles River Laboratories stock carries a USD 320 Evercore target dated September 11, 2026. Q2 reve

At the close on September 22, 2026, Charles River Labs stock reached USD 285.11, while the S&P 500 f

Charles River Laboratories stock closed at USD 278.06 on September 18, 2026, after a 1.28 percent de

Charles River Laboratories stock closed at USD 278.06 on September 18, 2026, 8.3 percent below its y

At the close on September 18, 2026, Charles River Labs stock stood at USD 278.06 on the NYSE after f

Charles River Labs stock recently closed at USD 277.71 on the NYSE, with analysts guiding FY 2026 EP

Riverwater Partners, an investment management company, released its ‘Sustainable Value Strategy’ Q2 2026 investor letter. The letter can be downloaded here. Small-cap stocks achieved their best first-half performance since 1991, with the Russell 2500 Value Index rising 17%, driven by the technology sector. The Sustainable Value Strategy underperformed its benchmark in the second quarter. The shortfall […]

At the close on September 18, 2026, Charles River Labs stock finished at 281.67 USD on its US listin

Charles River Labs stock most recently closed at USD 281.67 on September 18, 2026, near one fair val

Charles River Laboratories stock has rallied strongly into September 2026 after launching a rapid ce

Charles River Laboratories International introdujo recientemente programas rápidos de bancos de células que combinan métodos microbiológicos rápidos con secuenciación de próxima generación compatible con CGMP para acortar los plazos de los bancos de células y respaldar la calidad, la seguridad y la preparación regulatoria para productos biológicos y terapias avanzadas. La nueva plataforma, fortalecida por la adquisición de Pathoquest y por el enfoque del Proyecto de Avance de Métodos Alternativos de Charles River, refuerza las capacidades biológicas de extremo a extremo al tiempo que respalda un...